National Drug Abuse Treatment 

 PACIFIC REGION NODE


PACIFIC REGION NODE

Walter Ling, M.D.
Principal Investigator

Director
Integrated Substance Abuse Program, UCLA
11075 Santa Monica Blvd.
Suite 225
Los Angeles, CA 90025
lwater@ix.netcom.com
http://www.uclaisap.org/ctn/index.html (Node)
http://www.nida.nih.gov/CTN/centers/pacific.html (NIDA)

The Pacific Region Node joined the Clinical Trials Network in September 1999. The Pacific Region Node is a partnership between the University of California, Los Angeles Integrated Substance Abuse Program (the Regional Research and Training Center (RRTC)) and several community treatment programs in the State. The node incorporates researchers and clinicians from throughout California. Many of the CTP networks have been involved in the transfer of research into practice for over a decade. The diverse communities served by the CTPs have geographic areas with epidemic methamphetamine use, increasing rates of heroin use among youthful populations, endemic inner city crack cocaine use, and dramatically increasing reports of the use of ecstasy and GHB.


FIND IT!  Publications with Pacific Region involvement


PACIFIC REGION NODE PROTOCOL INVOLVEMENT

  Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification

Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification

Suboxone (Buprenorphine / Naloxone) Taper: A Comparison of Taper Schedules

MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics

Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics

Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs

Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

Brief Strategic Family Therapy for Adolescent Drug Abusers

Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment

Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment

Starting Treatment with Agonist Replacement Therapies (START)

 

Prescription Opioid Addiction Treatment Study (POATS)

  Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement




 

 
   


 


 

No web site available.
 

 

 




Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2008 -- http://ctndisseminationlibrary.org/nodes/prnode.htm
info@ctndisseminationlibrary.org